Making a difference in anaemia care

Anaemia can be a debilitating condition that affects the quality of life of people who are often already suffering from other illnesses, such as kidney disease or cancer.

At Roche, we research, develop and provide treatments for anaemia in kidney disease. The aim is to help patients regain the energy to continue to enjoy life.

We have a rich history of medical innovation in this field and a promising future with our focus on personalised healthcare - an approach that specifically takes into account emerging knowledge about the molecular pathology of diseases and of patients’ individual characteristics